Treatment of human lactation failure
CA 2086754 C · Owner: Gluckman, Peter · Inventors: Gluckman, Peter; Milsom, Stella R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of hGH hGRF, hIGF-1, hIGF-2 or analogs of , these or a mixture of two or more of these alone or in conjunction with lactational enhancers for the treatment of human lactation failure. It also relates to the use of hGH hGRF, hIGF-1, hIGF-2 or analogs of these or a mixture of two or more of these alone or in conjunction with lactational enhancers for the manufacturing of a medicament for the treatment of human lactation failure, also a prophylactic treatment. Preferably human growth hormone is used. The invention also relates to a method for the treatment of human lactation failure as well, as compositions and methods for their manufacturing.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 19, 1991 and granted August 29, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 19, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 19, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.